Mission
To prevail over cancer, marshaling heart and mind in bold scientific discovery, pioneering prevention and compassionate care.
Public Charity
Fox Chase Cancer Center Medical GroupIn
Based in Philadelphia, PA, Fox Chase Cancer Center Medical GroupIn operates as a Public Charity. The organization reported $116.5M in revenue, $115.7M in expenses, $59.1M in total assets for fiscal year 2025. Imperigo tracks 52 reported grant relationships connected to this organization totaling approximately $84.8M.
EIN: 454540585
Philadelphia, PA
Specialty Hospitals
NTEE: E24
Latest filing: 2025
Total Revenue$116.5M
Total Expenses$115.7M
Total Assets$59.1M
Grant Records52
Funding Total$84.8M
Filing Years2021–2025
Where $100 goes at Fox Chase Cancer Center Medical GroupIn
How Fox Chase Cancer Center Medical GroupIn divides every $100 it spends, from its own Form 990 filings, averaged across 6 years.
$93
Programs
the work itself
$7
Management
running the organization
$0
Fundraising
none reported
No fundraising costs are reported. That often means fundraising runs through a separate affiliated organization that files its own return.
Inside the $93 for programs
$19
Medical oncology
$18
Surgical oncology
$16
Medicine
Plus 5 more programs. Cost per person served and the full program breakdown are on the full profile.
Source: Form 990 filings with the IRS, latest fiscal year 2025. Shares are from the organization's reported expenses. Data by Imperigo; not affiliated with the IRS.
Sample Grants Received
GENERAL SUPPORT
$5,103
General Support
$454,925
For grant recipient's exempt purposes
$43,900
$42,450
BREAST CANCER RESEARCH
$39,224
Showing up to 5 of 52 total records — full history available with membership.
Officers & Directors
Associate Professor
Alexander Kutikov
Director
Amy Goldberg
Asst Secretary
Amy Montour
Director
Carl Sottosanti
Director/Chair
Chip W Marshall Iii
Director/Vice Chair
Christopher Mcnichol
Officer compensation and complete director data available with membership.
Top Grant Purposes
Financial Trends
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2025 | $116.5M | $115.7M | $59.1M |
| 2024 | $100.6M | $107.0M | $45.1M |
| 2023 | $89.7M | $93.6M | $37.1M |
| 2022 | $77.4M | $81.8M | $40.9M |
| 2021 | $82.3M | $80.4M | $37.9M |
Between 2021 and 2025, reported annual revenue grew from $82.3M to $116.5M (+42%), with total assets most recently reported at $59.1M.
Interactive year-over-year charts and full filing details available with membership.